000 | 01187 a2200337 4500 | ||
---|---|---|---|
005 | 20250513054743.0 | ||
264 | 0 | _c19940802 | |
008 | 199408s 0 0 eng d | ||
022 | _a0114-5916 | ||
024 | 7 |
_a10.2165/00002018-199410040-00004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrover, S A | |
245 | 0 | 0 |
_aRisk-benefit assessment of drug treatment to prevent coronary heart disease. Estimating the benefits of risk factor modification. _h[electronic resource] |
260 |
_bDrug safety _cApr 1994 |
||
300 |
_a301-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aComputer Simulation |
650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aLife Expectancy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aModels, Cardiovascular |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aCoupal, L | |
773 | 0 |
_tDrug safety _gvol. 10 _gno. 4 _gp. 301-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00002018-199410040-00004 _zAvailable from publisher's website |
999 |
_c8017630 _d8017630 |